D.E. Shaw & Co
INGN icon

D.E. Shaw & Co’s Inogen INGN Stock Holding History

D.E. Shaw & Co’s Portfolio INGN Stock Details INGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-33,200
Closed -$4.12M – 3740
2018
Q4 		$4.12M Hold
33,200
– – 0.01% 1640
2018
Q3 		$8.11M Buy
33,200
+23,300
+235% +$5.39M 0.01% 1236
2018
Q2 		$1.84M Buy
+9,900
New +$1.65M ﹤0.01% 2281

Other funds holding INGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co's INGN Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in Inogen (INGN) in Q1 2026: 46,643 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #4087 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in INGN as recently as Q4 2024.

D.E. Shaw & Co first reported a position in INGN in Q1 2015 and has held it in 25 quarters since. The position peaked at $24.9M in Q4 2019. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • D.E. Shaw & Co held 46,643 shares of Inogen worth $288K as of Q1 2026.
  • Inogen was a new D.E. Shaw & Co position in Q1 2026.
  • Inogen made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #4087 holding.
  • D.E. Shaw & Co first reported a position in Inogen in Q1 2015 and has held it in 25 quarters since.
  • D.E. Shaw & Co's Inogen position peaked at $24.9M in Q4 2019.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.